According to FDA prescribing information, these include: Nausea (occurring in 1544% of patients depending on the specific agent and dose) Vomiting (524% of patients) Diarrhea (821% of patients) Constipation (1024% of patients) Abdominal pain or discomfort (514% of patients) These symptoms typically emerge during dose initiation or escalation and often diminish over several weeks as the body adapts
Semaglutide is started at 0.25 mg weekly, then 0.5 mg after 4 weeks, and then 1.0 mg after another 4 weeks to mitigate nausea
The skin serves as a biosensor that can indicate underlying health conditions and is affected by nutritional status, lifestyle choices and environmental exposure
Whenever possible, it is advisable to consult with a professional before beginning a new treatment
Green tea extract (EGCG) tells a similar story
[1] [2] However, it is essential to inform your GP or prescribing clinician about all medications you are taking, including over-the-counter medicines and supplements